| Revenue | 139.05M |
| Cost of revenue | 54.83M |
| Gross profit | 84.22M |
| Research and development | 31.32M |
| Selling, general and administrative | 22.78M |
| Amortization of purchased intangibles | 2.67M |
| Restructuring | 14K |
| Acquisition-related costs | |
| Operating income | 22.8M |
| Interest income | |
| Interest expense and fees | -340K |
| (Loss) gain on deferred compensation investments, net | |
| Other-than-temporary impairment losses | |
| Income before income taxes | |
| Income tax expense | 7.03M |
| Net income (loss) | |
| Basic | 0.12 |
| Diluted | 0.11 |
| Cash dividends declared per common share | 0.12 |
| Basic | 135.91M |
| Diluted | 138.76M |